Where does Synthon Biopharmaceuticals B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Synthon Biopharmaceuticals B.V. ranks #27,551 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Synthon Biopharmaceuticals B.V. hold?

Synthon Biopharmaceuticals B.V. holds 10 US utility patents granted between 2016 and 2020, spanning 6 technology areas.

What is Synthon Biopharmaceuticals B.V.'s Innovation Score?

Synthon Biopharmaceuticals B.V. has an Innovation Score of 27.8 out of 100 (25th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Synthon Biopharmaceuticals B.V. focus on?

Synthon Biopharmaceuticals B.V.'s top technology area is C07K (Peptides) with 9 patents. Grants appear in 6 CPC subclasses total.

Is Synthon Biopharmaceuticals B.V.'s patent grant rate increasing or decreasing?

Synthon Biopharmaceuticals B.V.'s recent grant velocity is -89% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Synthon Biopharmaceuticals B.V.'s patents?

Synthon Biopharmaceuticals B.V.'s patents average 18.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Synthon Biopharmaceuticals B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Synthon Biopharmaceuticals B.V.

USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, recorded in grant years 2016–2020. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Synthon ranks #27,551 of 49,997 tracked US assignees by granted-patent volume, with 10 patents across 6 technology areas.

#27,551
of 49,997 US assignees by volume: 25th percentile
by Innovation Score (27.8/100): 18.1
avg claims per patent: -89%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R27551 · Foreign Corporation #27,551 · 10 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 10 grants
MID-PACK #27,551/49,997
PHOTO-FINISH Sutherland Global…
CPC-NARROW C07K · 6 areas
INNOV-THIN 27.8/100
CLAIMS-RICH 18.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -89% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sutherland Global Services Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Synthon Biopharmaceu… · this assignee

28
3D Lighting… · lowest

7

What this shows Synthon's Innovation Score is 27.8/100 (25th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Synthon's grants concentrate

Synthon Biopharmaceuticals B.V. is a focused PatentsView assignee: 6 CPC subclasses with 90% of grants classified under C07K (Peptides). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2020. By volume, Synthon sits between Sutherland Global Services Inc. and T. Hasegawa Co., Ltd..

Sutherland Global…

10
Sway Motorsports

10
Sympateco

10
Synopsys Taiwan

10
Syscend

10
Systimmune

10
System Instruments

10
T Hasegawa

10
Synthon Biopharma… ◀

10

What this shows Synthon holds 10 patents at rank #27,542, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Synthon

By rank, the assignees closest to #27,542 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Synthon's primary technology class.

Synthon's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 25th percentile higher than 25% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2020

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Synthon Biopharmaceuticals B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	20.0%
2017	3	30.0%
2018	2	20.0%
2019	2	20.0%
2020	1	10.0%

Which technologies does Synthon Biopharmaceuticals B.V. patent most?

C07K - Peptides 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 8

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

C07D - Heterocyclic Compounds 1

C12Y - Enzymes 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#27,551

of 49,997 tracked assignees

Innovation Score

27.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Synthon Biopharmaceuticals B.V.'s patent record in context - here's where to go next.

Synthon Biopharmaceuticals B.V.'s lead technology class is C07K (Peptides), 90% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #27,551 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Synthon Biopharmaceuticals B.V. against Sutherland Global Services Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 27.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.